Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

66.58
-0.3700-0.55%
Pre-market: 66.30-0.2800-0.42%07:00 EDT
Volume:5.54M
Turnover:368.73M
Market Cap:135.54B
PE:14.66
High:66.84
Open:66.77
Low:66.19
Close:66.95
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.82
T/O Rate:0.27%
Dividend:2.51
Dividend Rate:3.77%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:6.07
PE(LYR):19.24

Loading ...

Bristol Myers Shares Down 2% Premarket After Reuters Reports 'No Discussions' over AstraZeneca Deal

THOMSON REUTERS
·
Aug 05

Movement Alert|Bristol-Myers Squibb Falls 3.14% in Pre-Market Trading, Trading at $64.2

Market Focus
·
Aug 05

Argus Upgrades Bristol-Myers Squibb to Buy From Hold, Price Target is $75

MT Newswires Live
·
Aug 05

Exclusive-'Never was a Deal to be Done' Between AstraZeneca and Bristol Myers Squibb, Senior Source Close to Matter Says

THOMSON REUTERS
·
Aug 05

Bristol-Myers Squibb Company : Argus Research Raises to Buy from Hold

THOMSON REUTERS
·
Aug 05

Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs

Reuters
·
Aug 05

AstraZeneca deal talks with Bristol Myers remain active, Semafor says

TIPRANKS
·
Aug 05

U.S. Stocks on the MOVE-Expeditors International, Waters, Wayfair

Reuters
·
Aug 05

Bristol Myers Squibb Potential Deal With AstraZeneca Seen Unlikely as Shareholder Views Diverge, RBC Says

MT Newswires Live
·
Aug 04

Johnson & Johnson Names Tom Cavanaugh EVP, Worldwide Chairman of Innovative Medicine as Taubert Retires

Reuters
·
Aug 04

Bristol-Myers Squibb Announces Dividend of R$ 2.11 Per Unit for Q3 2026

Reuters
·
Aug 04

Bristol Myers Poised to Give up Modest Gains Tied to AstraZeneca Deal Talks

Reuters
·
Aug 04

Daiwa Securities Adjusts Bristol-Myers Squibb PT to $66 From $53, Maintains Neutral Rating

MT Newswires Live
·
Aug 04

UK's ConvaTec Meets Prelim H1 Revenue Estimates

Reuters
·
Aug 04

More Biotech M&A is Coming, Whether an AstraZeneca-Bristol Myers Deal Happens or Not

Dow Jones
·
Aug 04

A $400 Billion Pharma Merger? RBC Says Don't Bet On It

Options & Short Sell
·
Aug 04

PRESS Digest-British Business - August 4

Reuters
·
Aug 04

An AstraZeneca, Bristol Myers Squibb Merger Could Create a Cancer-Drug Giant, but Analysts Call it 'odd'

Dow Jones
·
Aug 04

Bristol-Myers Squibb is Maintained at Neutral by Citigroup

Dow Jones
·
Aug 04

TD Cowen sees no strategic logic in an AstraZeneca-Bristol Myers merger

TIPRANKS
·
Aug 04